
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
, “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
, “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
, “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
, “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
, “Statin use and risk of glioma: population-based case-control analysis”, Eur J Epidemiol, vol. 31, pp. 947-52, 2016.
, “Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis”, Ophthalmology, vol. 124, pp. 1635-1639, 2017.
, “Risk of stroke in patients with idiopathic Parkinson disease”, Parkinsonism Relat Disord, vol. 16, pp. 31-5, 2010.
, “The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions”, Headache, vol. 48, pp. 606-10, 2008.
, “Risk of incident depression in patients with Parkinson disease in the UK”, Eur J Neurol, vol. 18, pp. 448-53, 2011.
, “Parkinson disease and the risk of epileptic seizures”, Ann Neurol, vol. 83, pp. 363-374, 2018.
, “NSAID use and risk of Parkinson disease: a population-based case-control study”, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
, “Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis”, Int J Cancer, vol. 137, pp. 2424-31, 2015.
, “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
, “Migraine incidence, comorbidity and health resource utilization in the UK”, Cephalalgia, vol. 28, pp. 57-64, 2008.
, “Migraine and the risk of stroke, TIA, or death in the UK (CME)”, Headache, vol. 47, pp. 1374-84, 2007.
, “A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction”, Eur J Clin Pharmacol, vol. 72, pp. 1105-16, 2016.
, “Metformin does not alter the risk of lung cancer: a case-control analysis”, Lung Cancer, vol. 78, pp. 133-7, 2012.
, “Metformin and the risk of renal cell carcinoma: a case-control analysis”, Eur J Cancer Prev, vol. 26, pp. 257-262, 2017.
, “Metformin and the risk of head and neck cancer: a case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
, “Metformin and the risk of endometrial cancer: a case-control analysis”, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
, “Metabolic syndrome in relation to risk of meningioma”, Oncotarget, vol. 8, pp. 2284-2292, 2017.
, “Diabetes, use of metformin, and the risk of meningioma”, PLoS One, vol. 12, p. e0181089, 2017.
, “Diabetes in patients with idiopathic Parkinson's disease”, Diabetes Care, vol. 31, pp. 1808-12, 2008.
, “Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors”, Eye (Lond), vol. 32, pp. 1028-1035, 2018.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Cancer risk in association with Parkinson disease: a population-based study”, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
, “Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma”, Cancer Med, 2019.
, “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
, “Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study”, J Clin Endocrinol Metab, 2020.
, “ACE inhibitor use and risk of cataract: a case-control analysis”, Br J Ophthalmol, 2019.
,